Drug intelligence / Profile preview

Tocomore

Development stage: Unknown
Lead developer: Healthon Life Sciences
Modality: Small Molecules
Administration: Oral

Overview

Tocomore is a multi-ingredient dietary supplement developed and marketed by Healthon Lifesciences in India. It is formulated as a combination of antioxidants, vitamins, and minerals designed to support general wellness, cardiovascular health, and immune function. The standard formulation includes astaxanthin, coenzyme Q10 (ubidecarenone), docosahexaenoic acid (DHA), L-carnitine, lycopene, magnesium bisglycinate, tocotrienols, and zinc. A variant, Tocomore M, utilizes ubiquinol instead of ubiquidecarenone. As a nutraceutical product, it functions by providing nutritional support and antioxidant protection rather than targeting a specific disease-related biological receptor.

Brand names: TocomoreTocomore M

Beyond the preview

Go deeper on Tocomore.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tocomore.

Explore the full profile